Beauty Health (NASDAQ:SKIN) Earns “Hold” Rating from Canaccord Genuity Group

Beauty Health (NASDAQ:SKIN)‘s stock had its “hold” rating reissued by Canaccord Genuity Group in a report issued on Friday,Benzinga reports. They currently have a $1.50 price target on the stock. Canaccord Genuity Group’s price objective suggests a potential upside of 18.11% from the company’s current price.

Other research analysts have also recently issued reports about the company. Benchmark reissued a “hold” rating on shares of Beauty Health in a research note on Friday. TD Cowen raised their price target on Beauty Health from $1.50 to $1.65 and gave the stock a “hold” rating in a research report on Wednesday, January 21st. Jefferies Financial Group reiterated a “hold” rating and set a $1.60 price objective on shares of Beauty Health in a report on Wednesday, January 14th. Finally, Zacks Research lowered Beauty Health from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus target price of $2.45.

Beauty Health Trading Up 19.8%

SKIN opened at $1.27 on Friday. The firm’s fifty day moving average is $1.27 and its two-hundred day moving average is $1.51. The firm has a market cap of $161.93 million, a PE ratio of -6.35 and a beta of 1.20. Beauty Health has a twelve month low of $0.78 and a twelve month high of $2.69. The company has a debt-to-equity ratio of 5.53, a quick ratio of 4.07 and a current ratio of 4.98.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings results on Thursday, March 12th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.01. Beauty Health had a negative net margin of 3.16% and a negative return on equity of 15.35%. The company had revenue of $82.37 million during the quarter, compared to analyst estimates of $78.07 million. Equities research analysts anticipate that Beauty Health will post -0.25 EPS for the current year.

Institutional Investors Weigh In On Beauty Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SKIN. Mirabella Financial Services LLP lifted its position in Beauty Health by 21.3% during the 3rd quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock worth $31,037,000 after buying an additional 2,734,728 shares in the last quarter. Woodline Partners LP grew its holdings in shares of Beauty Health by 255.9% in the 3rd quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock valued at $11,801,000 after acquiring an additional 4,263,997 shares in the last quarter. Millennium Management LLC grew its holdings in shares of Beauty Health by 127.0% in the 4th quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock valued at $8,013,000 after acquiring an additional 3,225,668 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Beauty Health by 27.5% in the second quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock valued at $4,399,000 after acquiring an additional 496,963 shares during the last quarter. Finally, State Street Corp increased its position in shares of Beauty Health by 0.9% in the fourth quarter. State Street Corp now owns 1,871,527 shares of the company’s stock valued at $2,601,000 after acquiring an additional 16,493 shares during the last quarter. 93.26% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Beauty Health

Here are the key news stories impacting Beauty Health this week:

• Positive Sentiment: Q4 results topped consensus on both revenue and EPS — revenue of ~$82.4M beat estimates and EPS of ($0.06) came in slightly better than the consensus loss. That beat helped lift sentiment after the print. Press Release
• Positive Sentiment: Analyst coverage: Canaccord reaffirmed a Hold and set a $1.50 price target — the reminder of analyst support and a PT above the current price provides incremental upside narrative for traders. Canaccord / Coverage Note
• Neutral Sentiment: Company outlined a 2026 revenue target of $285M–$305M and emphasized installed‑base utilization and product innovation as growth drivers — the plan signals a path to growth but the top‑line target is only roughly in line with Street expectations. Revenue Target Article
• Neutral Sentiment: Full earnings call and transcript are available for investors who want detail on margin dynamics, installed base metrics and management guidance assumptions. Useful if you trade around guidance cadence. Earnings Call Transcript
• Negative Sentiment: Q1 2026 revenue guidance was set at $63M–$68M, below the consensus ~ $68.6M — this softer near‑term guide may pressure sentiment if investors were expecting a stronger seasonal ramp. Guidance in Press Release
• Negative Sentiment: Profitability and balance-sheet items remain a concern: the company recorded a small net loss, operating profit was negligible, and cash & cash equivalents declined year‑over‑year — these metrics limit runway visibility until growth accelerates. Financial Highlights / QuiverQuant

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.